In Focus
›
Stories
Pharma company Viiv's attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India
- Published on
Impact Stories
Related News & stories
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Refugees and Migrants
Press release |
Jan 2, 2026 |
Pakistan: Harsh winter worsens the Afghan refugee crisis amid forced deportations
Attacks on medical care
News & Stories |
Dec 31, 2025 |